KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

80 hedge funds and large institutions have $456M invested in Chinook Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 80 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$66K
Puts
$231K
Net Calls
Net Calls Change

Top Buyers

1
+$157M
2
+$63.9M
3
+$34.9M
4
O
OrbiMed
New York
+$32.3M
5
Jennison Associates
Jennison Associates
New York
+$22.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$238K
52
$232K
53
$232K
54
$215K
55
$175K
56
$170K
57
$164K
58
$148K
59
$142K
60
$124K
61
$81K
62
$41K
63
$37K
64
$31K
65
$22K
66
$21K
67
$15K
68
$8K
69
$6K
70
$6K
71
$5K
72
$5K
73
$5K
74
$3K
75
$3K
1 2
3
4